The biotechnology industry in the United States is a dynamic and rapidly evolving sector that plays a crucial role in advancing medical research, developing new therapies, and improving healthcare outcomes. The leading companies in this field are at the forefront of innovation, bringing groundbreaking technologies and treatments to market. In this article, we will explore some of the top companies in the U.S. biotechnology market, including Johnson & Johnson Services, Inc., Amgen Inc., Pfizer, Inc., Abbott Laboratories, Biogen, Bristol-Myers Squibb, Gilead Sciences, Inc., NVIDIA Healthcare, and Walgreens.

Pfizer, Inc.

Pfizer, Inc. is a household name in the pharmaceutical and biotechnology sectors. With a history spanning over 170 years, Pfizer has been at the forefront of numerous medical breakthroughs. The company is well-known for its development of vaccines, including the highly effective COVID-19 vaccine in partnership with BioNTech. Pfizer’s research and development efforts encompass a wide range of therapeutic areas, including oncology, immunology, and rare diseases.

Key Contributions:

  • Development of the COVID-19 mRNA vaccine.
  • Cutting-edge research in oncology and rare diseases.
  • Advancements in immunotherapy and precision medicine.

Pfizer Pipeline to the U.S. Biotechnology Market

Company Name Pfizer
Headquarters New York, United States
Pipeline In February 2024, Pfizer announced that it is turning to target cancer more closely, putting a special emphasis on small compounds, bispecific antibodies, and next-generation antibody-drug conjugates (ADCs). This change in approach comes after Seagen, a biotech company creating ADCs for cancer treatment, was acquired last year. With the $43 billion transaction, Pfizer now has 60 cancer initiatives, quadrupling its previous level. Big Pharma is now promoting a pipeline that claims to have the potential to produce at least eight blockbuster drugs by 2030 during an innovation day on Thursday.

Johnson & Johnson Services, Inc.

Johnson & Johnson Services, Inc. is a global leader in the biotechnology and pharmaceutical industry. Known for its diverse portfolio, Johnson & Johnson develops a wide range of products, including pharmaceuticals, medical devices, and consumer health products. The company is renowned for its research and development efforts, which focus on areas such as oncology, immunology, and infectious diseases. With a commitment to improving global health, Johnson & Johnson continues to invest in innovative solutions that address some of the most pressing medical challenges.

Key Contributions:

  • Development of pioneering cancer therapies.
  • Advancements in immunotherapy for chronic diseases.
  • Significant contributions to the fight against infectious diseases, including the development of vaccines.

Johnson & Johnson Services Inc. Pipeline to the U.S. Biotechnology Market

Company Name Johnson & Johnson Services Inc.
Headquarters New Jersey, United States
Pipeline In May 2024,¬†Proteologix Inc., a privately owned biotechnology firm focused on bispecific antibodies for immune-mediated disorders, and Johnson & Johnson reached a formal deal to acquire the former for $850 million in cash with the possibility of an additional milestone payment. Two bispecific antibodies, PX130, which targets IL-13 plus TSLP and is ready to enter phase 1 development for moderate to severe asthma and atopic dermatitis (AD), are in Proteologix’s portfolio.

U.S. Biotechnology Market Size 2023 - 2033

Download a sample of this report @

Amgen Inc.

Amgen Inc. is one of the world’s leading biotechnology companies, dedicated to unlocking the potential of biology for patients suffering from serious illnesses. Amgen’s innovative therapies have transformed the treatment landscape for diseases such as cancer, cardiovascular diseases, and autoimmune disorders. The company’s robust pipeline and commitment to cutting-edge research make it a key player in the biotech industry.

Key Contributions:

  • Development of biologic therapies for cancer and cardiovascular diseases.
  • Innovations in biosimilars, offering affordable treatment options.
  • Extensive research in gene therapies and regenerative medicine.

Abbott Laboratories

Abbott Laboratories is a global healthcare leader that specializes in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Abbott’s innovative products are designed to improve health outcomes and quality of life for people around the world. The company’s commitment to innovation is evident in its extensive portfolio of products, which includes groundbreaking diagnostic technologies and life-saving medical devices.

Key Contributions:

  • Development of rapid diagnostic tests for infectious diseases.
  • Innovations in diabetes care and management.
  • Pioneering advancements in cardiovascular devices and therapies.


Biogen is a biotechnology company that focuses on discovering, developing, and delivering innovative therapies for neurological and neurodegenerative diseases. With a strong emphasis on neuroscience, Biogen is committed to addressing some of the most challenging conditions, such as Alzheimer’s disease, multiple sclerosis, and spinal muscular atrophy. The company’s groundbreaking research and development efforts have led to the introduction of several life-changing therapies.

Key Contributions:

  • Development of therapies for multiple sclerosis and spinal muscular atrophy.
  • Innovative research in Alzheimer’s disease and other neurodegenerative conditions.
  • Commitment to advancing neuroscience through cutting-edge research.

Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. The company’s research and development efforts focus on areas such as oncology, immunology, and cardiovascular diseases. Bristol-Myers Squibb’s mission is to transform patients’ lives through science, and its extensive portfolio of therapies reflects this commitment.

Key Contributions:

  • Development of breakthrough immunotherapies for cancer.
  • Advancements in treatments for autoimmune diseases.
  • Significant research in cardiovascular therapies.

Gilead Sciences, Inc.

Gilead Sciences, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need. Gilead’s portfolio includes treatments for HIV/AIDS, liver diseases, cancer, and inflammatory and respiratory diseases. The company’s commitment to innovation and patient care has made it a leader in the biotech industry.

Key Contributions:

  • Development of groundbreaking HIV/AIDS therapies.
  • Innovative treatments for liver diseases, including hepatitis C.
  • Research and development of therapies for cancer and inflammatory diseases.

NVIDIA Healthcare

NVIDIA Healthcare is a division of NVIDIA Corporation that leverages the company’s expertise in artificial intelligence (AI) and high-performance computing to revolutionize healthcare and life sciences. NVIDIA’s technology enables advanced research in areas such as genomics, medical imaging, and drug discovery. By harnessing the power of AI, NVIDIA Healthcare is transforming the way medical professionals diagnose, treat, and prevent diseases.

Key Contributions:

  • AI-powered advancements in medical imaging and diagnostics.
  • Accelerated drug discovery and development processes.
  • Cutting-edge research in genomics and personalized medicine.


Walgreens is a well-known retail pharmacy chain that also plays a significant role in the biotechnology sector through its healthcare services and partnerships. Walgreens provides a range of healthcare services, including immunizations, health screenings, and chronic disease management. The company’s commitment to accessible healthcare and its extensive network of pharmacies make it a vital player in the U.S. healthcare system.

Key Contributions:

  • Provision of immunizations and health screenings.
  • Management and support for chronic disease patients.
  • Partnerships with biotech companies to enhance healthcare services.

In conclusion, the biotechnology industry in the United States is driven by a group of pioneering companies that are dedicated to advancing medical science and improving patient outcomes. From developing life-saving therapies to leveraging AI for innovative research, these companies are at the forefront of healthcare innovation. Their contributions have a profound impact on the lives of millions of people worldwide, and their ongoing efforts continue to shape the future of medicine.

Read more about U.S. Biotechnology Market:

To own our research study instantly, Click here @

You can place an order or ask any questions, please feel free to contact us at

About Us

Healthcare Web Wire is a premier subsidiary of Towards Healthcare, dedicated to providing comprehensive insights and information related to the healthcare industry. With a commitment to delivering accurate and timely updates, Healthcare Web Wire serves as a vital resource for professionals, enthusiasts, and stakeholders within the healthcare sector. Our platform serves as a central hub for the latest news, trends and developments shaping the healthcare landscape. Join us on Healthcare Web Wire and become part of a vibrant community dedicated to advancing healthcare knowledge and shaping the future of healthcare worldwide.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us:

By Elena Morales

Elena Morales is a healthcare industry expert working at Healthcare Web Wire Consulting Firm, a subsidiary of Towards Healthcare. With her excellent knowledge of the field, Elena helps clients optimize their operations and navigate healthcare regulations. She's dedicated to staying updated on industry trends to make a positive impact on patient care. Elena is known for her professionalism and commitment to excellence, making her a valuable asset to any team.